LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 15.58 | 27.76 | 598 | 685 | 0.8723 | 0.9418 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 15.58 | 27.76 | 18 | 685 | 0.0263 | -0.0894 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 15.58 | 27.76 | 914 | 685 | 1.3332 | 1.1283 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 17.28 | 27.76 | 1 | 838 | 0.0012 | -0.4913 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 17.28 | 27.76 | 605 | 838 | 0.7213 | 0.8715 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 17.28 | 27.76 | 23 | 838 | 0.0274 | -0.0375 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 17.28 | 27.76 | 931 | 838 | 1.1100 | 1.0429 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.98 | 27.76 | 1 | 941 | 0.0011 | -0.4799 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.98 | 27.76 | 602 | 941 | 0.6397 | 0.8317 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.98 | 27.76 | 35 | 941 | 0.0372 | 0.0467 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.98 | 27.76 | 923 | 941 | 0.9807 | 0.9924 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.68 | 27.76 | 1 | 1119 | 0.0009 | -0.4638 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.68 | 27.76 | 610 | 1119 | 0.5451 | 0.7849 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.68 | 27.76 | 28 | 1119 | 0.0250 | 0.0016 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 20.68 | 27.76 | 926 | 1119 | 0.8275 | 0.9303 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 22.39 | 27.76 | 1 | 1305 | 0.0008 | -0.4502 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 22.39 | 27.76 | 602 | 1305 | 0.4611 | 0.7398 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 22.39 | 27.76 | 33 | 1305 | 0.0253 | 0.0316 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 22.39 | 27.76 | 921 | 1305 | 0.7054 | 0.8782 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.09 | 27.76 | 2 | 1461 | 0.0014 | -0.3687 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.09 | 27.76 | 605 | 1461 | 0.4139 | 0.7141 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.09 | 27.76 | 32 | 1461 | 0.0219 | 0.0252 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 24.09 | 27.76 | 900 | 1461 | 0.6158 | 0.8374 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.79 | 27.76 | 1 | 1605 | 0.0006 | -0.4332 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 25.79 | 27.76 | 605 | 1605 | 0.3769 | 0.6929 | MN20160318_Q01 | E13 |